NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

EU15個國家的麻醉、呼吸、睡眠治療用設備市場、COVID-19的影響 (2021-2027年) -MedSuite

EU15 Anesthesia, Respiratory & Sleep Therapy Devices Market-COVID19-2021-2027-MedSuite-Includes: Anesthesia Devices (Disposables, Monitors, Delivery Units), Respiratory Devices & Sleep Management Devices

出版商 iData Research Inc. 商品編碼 1000936
出版日期 內容資訊 英文 588 Pages
商品交期: 最快1-2個工作天內
價格
EU15個國家的麻醉、呼吸、睡眠治療用設備市場、COVID-19的影響 (2021-2027年) -MedSuite EU15 Anesthesia, Respiratory & Sleep Therapy Devices Market-COVID19-2021-2027-MedSuite-Includes: Anesthesia Devices (Disposables, Monitors, Delivery Units), Respiratory Devices & Sleep Management Devices
出版日期: 2021年03月26日內容資訊: 英文 588 Pages
簡介

歐洲的麻醉、呼吸、睡眠治療用設備的市場規模2020年顯示19億歐元的規模。可是,ASP低和新型冠狀病毒感染疾病 (COVID-19)的影響造成市場的重新評估抵消銷售數的成長,在預測期間中若干縮小,預計2027年顯示18億歐元的規模。

該市場的目標人口層中,包含接受手術的患者和老年人。隨著全球的空氣品質降低,預計慢性阻塞性肺病(COPD)等呼吸系統疾病的發病率增加。同時,短期性,由於COVID-19的影響各種手術大規模的取消和延期發生,給予市場負面影響。

本報告提供EU15個國家的麻醉、呼吸、睡眠治療用設備的市場調查,市場概要,市場成長的促進因素、抑制因素,市場規模、銷售數、ASP的變化、預測,各產品種類的詳細分析,競爭分析,企業佔有率,企業及企業間的發展等資料彙整。

對象市場

麻醉監控器市場-MedCore

麻醉輸送單位(ADU)設備市場-MedCore

麻醉用拋棄式用品市場-MedCore

人工呼吸器市場-MedCore

噴霧器市場-MedCore

氧氣療法市場-MedCore

閉塞性睡眠呼吸中止症治療設備市場-MedCore

睡眠障礙診斷設備市場-MedCore

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: iDATA_EUARS21_MS

Throughout this medical market research, the publisher analyzed 84+ Anesthesia, Respiratory and Sleep Management companies in Europe and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.

While this report suite report contains all of the EU15 Anesthesia, Respiratory and Sleep Management market analysis, each of the market segments is also available as a stand-alone a report, MedCore.

Markets Covered:

Anesthesia Monitors Market | Europe | 2021-2027 | MedCore

Anesthesia Delivery Unit (ADU) Devices Market | Europe | 2021-2027 | MedCore

Anesthesia Disposables Market | Europe | 2021-2027 | MedCore

Ventilator Market | Europe | 2021-2027 | MedCore

Nebulizer Market | Europe | 2021-2027 | MedCore

Oxygen Therapy Market | Europe | 2021-2027 | MedCore

Therapeutic Obstructive Sleep Apnea Device Market | Europe | 2021-2027 | MedCore

Sleep Diagnostic Devices Market | Europe | 2021-2027 | MedCore

Europe Anesthesia, Respiratory and Sleep Management Market Insights

Overall, the European market for anesthesia, respiratory and sleep management devices was valued at nearly €1.9 billion in 2020 and will decline slightly over the forecast period, due to the declining ASPs and market corrections post-COVID offsetting growth in unit sales, to €1.8 billion in 2027.

The ARS market demographic includes surgery patients and senior citizens. With the decline in global air quality, illnesses of the respiratory tract, such as chronic obstructive pulmonary disease (COPD), will increase in incidence. This growth will also affect the ARS market. As the awareness and the frequency of diagnoses, as well as self-diagnoses, increases, so will the population of individuals requiring some form of treatment from this market. In the short term, however, the market was negatively impacted by COVID-19 due to mass cancellations and postponements of surgeries across all countries.

In 2020, ResMed was the leading competitor in the anesthesia, respiratory and sleep management device market. The company led the therapeutic obstructive sleep apnea device market in Europe, with a notable presence in both the sleep therapy interface and PAP device segments. This segment is so large that it positioned ResMed as the overall market leader.